ScholarIQanswers from OpenAlex

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease

PaperCitations, authors & open-access status

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease have?

ScholarIQcitation count

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease has 157 citations in the OpenAlex counts ScholarIQ stores.

When was Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease published?

ScholarIQyear

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease has 2023 year in the ScholarIQ index.

What is the open-access status of Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease?

ScholarIQoa status

Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease has hybrid oa status in the ScholarIQ index.

What is the DOI of Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease?

ScholarIQdoi

The DOI for Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease is on the source record.

What is the PMID of Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease?

ScholarIQpmid

The PMID for Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease is on the source record.

What is the OpenAlex record for Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease?

ScholarIQopenalex

The OpenAlex for Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial